Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 1;109(6):2000-2004.
doi: 10.3324/haematol.2023.284581.

The outcome of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia and a predictive model from the Chinese Blood and Marrow Transplant Registry group

Zheng-Li Xu  1 , Lan-Ping Xu  1 , Yi-Cheng Zhang  2 , Yu-Hong Zhou  3 , Er-Lie Jiang  4 , Jian-Ping Zhang  5 , Bin Fu  6 , Gui-Fang Ouyang  7 , Xian-Min Song  8 , Xue-Jun Zhang  9 , Yu-Jun Dong  10 , Nai-Nong Li  11 , Ling Wang  12 , Xi Zhang  13 , Peng-Cheng He  14 , Fan-Sheng Kong  15 , Hui-Xia Liu  16 , Li Liu  17 , Lin Liu  18 , Tai-Wu Xiao  19 , Wen-Wei Xu  20 , Xiao-Jun Xu  21 , Guo-Lin Yuan  22 , Hai Yi  23 , Dan Yu  24 , Li Yu  25 , Xiao-Jun Huang  26
Affiliations

The outcome of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia and a predictive model from the Chinese Blood and Marrow Transplant Registry group

Zheng-Li Xu et al. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The overall survival of patients with severe aplastic anemia older than 50 years who underwent allogeneic hematopoietic stem cell transplantation from different donors. HID: haploidentical donor; MSD: matched sibling donor; URD: unrelated donor.
Figure 2.
Figure 2.
The probabilities of overall survival for low-risk, intermediate-risk, and high-risk groups among patients with severe aplastic anemia older than 50 years of age. Older age (≥55 years), higher Hematopoietic Cell Transplantation Comorbidity Index score (≥2), and ABO blood type incompatibility were factors predictive of poorer survival. Based on these three parameters, a predictive risk model was established: low risk (0 factors), intermediate risk (1 factor), and high risk (2-3 factors).
See this image and copyright information in PMC

References

    1. Georges GE, Doney K, Storb R. Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment. Blood Adv. 2018;2(15):2020-2028. - PMC - PubMed
    1. Devillier R, Dalle JH, Kulasekararaj A, et al. . Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party. Haematologica. 2016;101(7):884-890. - PMC - PubMed
    1. Rice C, Eikema DJ, Marsh JCW, et al. . Allogeneic hematopoietic cell transplantation in patients aged 50 years or older with severe aplastic anemia. Biol Blood Marrow Transplant. 2019;25(3):488-495. - PMC - PubMed
    1. Xu LP, Xu ZL, Wang SQ, et al. . Long-term follow-up of haploidentical transplantation in relapsed/refractory severe aplastic anemia: a multicenter prospective study. Sci Bull (Beijing). 2022;67(9):963-970. - PubMed
    1. Xu ZL, Xu LP, Wu DP, et al. . Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study. Haematologica. 2022;107(12):2918-2927. - PMC - PubMed

Publication types

LinkOut - more resources